Inhibition of HSP70 by peptide aptamer A17 exerts the radiosensitizing effect on breast and lung cancers as the co-administration of aptamer A17 and Hsp90 inhibitor NVP-AUY922 significantly enhance DNA double-strand breaks and cell cycle arrest in cancer cells [128]. This evidence concerns the gene HSP90AB1 and lung cancer.